Page 21 - Umer Raffat News Today

Close icon Two crossed lines that form an X. It indicates a way to close an interaction, or dismiss a notification. Samantha Lee/Insider Public-health experts are feeling unusually optimistic about this summer and the pandemic.  Insider talked to 18 experts, many of whom plan to travel, see family, and even go to the movies.  Heres why you should be optimistic for the summer and how to have fun while making smart decisions. Public-health experts are experiencing a novel ...

ELANCO ANIMAL HEALTH INC (ELAN) Q4 2020 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. ELANCO ANIMAL HEALTH INC (NYSE: ELAN) Popular Searches Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the Elanco Animal Health Q4 2020 Earnings Conference Call. [Operator Instruction] Following the presentation, we will conduct a question-and-answer session, open to analysts only. [Operator Ins...

In letters published in The New England Journal of Medicine, Pfizer and Moderna acknowledged that laboratory experiments showed their mRNA vaccines aren't as potent against the aggressive new COVID-19 variant identified in South Africa. Wall Street analysts are worried.

Repros Therapeutics (RPRX) Q4 2020 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Repros Therapeutics (NASDAQ: RPRX) Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma fourth-quarter 2020 financial results conference call. I would now like to turn the call over to George Grofik, senior vice president, head of investor relations and communications. Please go ahead, sir. George Grofik -- ...

Operator Ladies and gentlemen, thank you for standing by. Welcome to todays Teva fourth-quarter and full-year 2020 financial results. [Operator instructions] I must advise you that this conference is being recorded today, Wednesday, the 10th of February 2021. I would now like to hand the conference over to your speaker today, Kevin Mannix, senior vice president, head of investor relations. Please go ahead, sir. Senior Vice President, Head of Investor Relations Thank you, Sharon. And thank you, ...

Pfizer Inc. projected about $15 billion in revenue this year from the Covid-19 vaccine it developed with BioNTech SE, but the shares fell amid questions about the durability of the market for the shot.

Pfizer, the first company to get U.S. emergency use authorization for a COVID-19 vaccine, swung to a small profit in the fourth-quarter as it started shipping vaccines globally. The drugmaker expects roughly $15 billion in revenue this year from the vaccine, which won emergency clearance in mid-December from U.S. regulators and continues to rack up approvals across the globe. The two-dose vaccine is about 95% effective and is one of only a few vaccines available to check the global pandemic. ...

Pfizer Projects $15 Billion in 2021 Sales of Covid Vaccine Bloomberg 2/2/2021 Riley Griffin (Bloomberg) -- Pfizer Inc. projected about $15 billion in revenue this year from the Covid-19 vaccine it developed with BioNTech SE, but the shares fell amid questions about the durability of the market for the shot. Company officials led by Chief Executive Albert Bourla said on a conference call that the vaccine looks capable of taking on new variants, its price may increase and new pr...

NewsSportsTicketLifestyleOpinionUSA TODAYObituariesE-EditionLegals CORPORATE REPORT: UPS, Pfizer surpass Wall Street expectations; Tesla agrees to recall Oil giants Exxon and BP report staggering losses for 2020 as the pandemic crushes energy demand and undercuts oil prices. Sarasota Herald-Tribune A surge in online shopping helped United Parcel Service (UPS) post record revenue during the last three months of 2020, the company said on Tuesday. Its stock rose nearly 5% in early trading. UPS...

MONEYWEB app instead? Pfizer forecasts R225bn in Covid vaccine sales for 2021 And may generate additional revenue from a booster shot being developed to combat the ‘South African’ variant. By Riley Griffin, Bloomberg 2 Feb 2021  20:13  The pharma giant spent more than $9bn on R&D in 2020. Image: Christinne Muschi, Bloomberg Pfizer Inc said it expects about $15 billion (close to R225 billion) in revenue this year from the Covid-19 vaccine it developed with BioNTech SE, a sign of...